CXCL5 and prostate cancer: For example, increased secretion of CXCL5 in prostate cancers is known to recruit MDSCs and Treg cells to the tumor microenvironment, which blocks cytotoxic T cell activity and protects tumor cells from T cell-mediated cell death [113].